Linked Life Data

17892918

Source:http://linkedlifedata.com/resource/pubmed/id/17892918

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-2-11
pubmed:abstractText
Limiting the neurocognitive sequelae of radiotherapy (RT) has been an objective in the treatment of medulloblastoma. Conformal RT to less than the entire posterior fossa (PF) after craniospinal irradiation might reduce neurocognitive sequelae and requires evaluation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-10487567, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-10561268, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-10944134, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-10965272, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-11352962, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-11481352, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-11550312, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-11878577, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-12697884, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-12845195, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-12915597, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-13057640, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-13471920, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-14752880, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-15001259, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-15001263, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-15231246, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-15788715, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-16110011, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-16472938, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-16943538, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-17012043, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-230440, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-597384, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-7493846, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-7753996, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-831755, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-8598368, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-9586884, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-9724122, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-9747831, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-9810786, http://linkedlifedata.com/resource/pubmed/commentcorrection/17892918-9893634
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0360-3016
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
70
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
782-7
pubmed:dateRevised
2011-2-24
pubmed:meshHeading
pubmed-meshheading:17892918-Adolescent, pubmed-meshheading:17892918-Adult, pubmed-meshheading:17892918-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17892918-Cerebellar Neoplasms, pubmed-meshheading:17892918-Child, pubmed-meshheading:17892918-Child, Preschool, pubmed-meshheading:17892918-Cisplatin, pubmed-meshheading:17892918-Cognition Disorders, pubmed-meshheading:17892918-Combined Modality Therapy, pubmed-meshheading:17892918-Cyclophosphamide, pubmed-meshheading:17892918-Disease-Free Survival, pubmed-meshheading:17892918-Female, pubmed-meshheading:17892918-Humans, pubmed-meshheading:17892918-Infratentorial Neoplasms, pubmed-meshheading:17892918-Male, pubmed-meshheading:17892918-Medulloblastoma, pubmed-meshheading:17892918-Prospective Studies, pubmed-meshheading:17892918-Radiotherapy, Conformal, pubmed-meshheading:17892918-Radiotherapy Dosage, pubmed-meshheading:17892918-Tumor Burden, pubmed-meshheading:17892918-Vincristine
pubmed:year
2008
pubmed:articleTitle
Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
pubmed:affiliation
Department of Radiological Sciences, Division of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. thomas.merchant@stjude.org
More...